Bart Vansteenkiste

Bart Vansteenkiste has worked for Domino for over 12 years in different commercial roles. A master degree of Electromechanical Engineering and his former role as Pharmaceutical and OEM key account manager for Belgium gave him the perfect background to join the headquarters based FMD group in 2011. Within this group Bart is focussing on the legislative and technical challenges facing the healthcare sector. Bart regularly attends and presents at conferences across Europe on behalf of Domino. Bart is fluent in Dutch, English, French and Spanish.

October 12, 2020

COVID-19: Key considerations when printing onto masks

Understanding how to add the necessary codes to masks is crucial for manufacturers – both for the efficiency of their business and the safety of their customers. There are health risks associated with incorrect coding practices. And different types of mask have different coding requirements. Let’s outline the key considerations.

BLOG

October 16, 2012

Other Pharma Emerging Legislation

The pharmaceutical sector is facing its greatest challenge to date; how to reduce the number of counterfeit and falsified medicines entering the legitimate supply chain.

BLOG

March 17, 2012

China CFDA eCode

The China Food and Drug Administration (CFDA) work to ensure the safety of food and healthcare products in the Chinese market. The drug regulation aims to protect patients from counterfeit pharmaceuticals and counterfeit traditional Chinese medicines.

BLOG

Bart Vansteenkiste

Articles from Bart Vansteenkiste

COVID-19: Key considerations when printing onto masks

Other Pharma Emerging Legislation

China CFDA eCode